440 related articles for article (PubMed ID: 31028691)
1. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial.
Arenas-Pinto A; Thompson J; Musoro G; Musana H; Lugemwa A; Kambugu A; Mweemba A; Atwongyeire D; Thomason MJ; Walker AS; Paton NI;
J Neurovirol; 2016 Feb; 22(1):104-13. PubMed ID: 26323809
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.
Tumusiime DK; Venter F; Musenge E; Stewart A
BMC Public Health; 2014 Dec; 14():1306. PubMed ID: 25526665
[TBL] [Abstract][Full Text] [Related]
4. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Peripheral Neuropathy and associated factors in HIV-infected patients.
Benevides MLACSE; Filho SB; Debona R; Bergamaschi ENC; Nunes JC
J Neurol Sci; 2017 Apr; 375():316-320. PubMed ID: 28320159
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of dyslipidaemia among HIV-infected patients receiving combination antiretroviral therapy in North Shewa, Ethiopia.
Fiseha T; Alemu W; Dereje H; Tamir Z; Gebreweld A
PLoS One; 2021; 16(4):e0250328. PubMed ID: 33905435
[TBL] [Abstract][Full Text] [Related]
7. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy.
Kallianpur AR; Hulgan T; Canter JA; Ritchie MD; Haines JL; Robbins GK; Shafer RW; Clifford DB; Haas DW
AIDS; 2006 Jul; 20(11):1503-13. PubMed ID: 16847405
[TBL] [Abstract][Full Text] [Related]
8. Peripheral neuropathy and quality of life of adults living with HIV/AIDS in the Rulindo district of Rwanda.
Biraguma J; Rhoda A
SAHARA J; 2012; 9(2):88-94. PubMed ID: 23237043
[TBL] [Abstract][Full Text] [Related]
9. Peripheral neuropathy in ART-experienced patients: prevalence and risk factors.
Chen H; Clifford DB; Deng L; Wu K; Lee AJ; Bosch RJ; Riddler SA; Ellis RJ; Evans SR
J Neurovirol; 2013 Dec; 19(6):557-64. PubMed ID: 24297499
[TBL] [Abstract][Full Text] [Related]
10. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy.
Mehta SA; Ahmed A; Laverty M; Holzman RS; Valentine F; Sivapalasingam S
Clin Infect Dis; 2011 Sep; 53(5):490-6. PubMed ID: 21844033
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors among patients with human immunodeficiency viral infection at a tertiary hospital in Ghana: a cross-sectional study.
Sanuade OA; Baatiema L; Christian AK; Puplampu P
Pan Afr Med J; 2021; 38():317. PubMed ID: 34285740
[TBL] [Abstract][Full Text] [Related]
13. Haematological Changes among HIV-Positive Persons on Antiretroviral Therapy at a Tertiary Hospital in Ghana.
Obiri-Yeboah D; Charwudzi A; Baidoo IK; Botchway ET; Addo SA; Nsiah P; Ekem I
West Afr J Med; 2020; 37(1):40-47. PubMed ID: 32030710
[TBL] [Abstract][Full Text] [Related]
14. HIV peripheral neuropathy.
Gabbai AA; Castelo A; Oliveira AS
Handb Clin Neurol; 2013; 115():515-29. PubMed ID: 23931799
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
[TBL] [Abstract][Full Text] [Related]
17. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study.
Adem KS; Janakiraman B; Gebremeskel BF; Chala MB; Gelaw AY; Alemu K
PLoS One; 2019; 14(1):e0211354. PubMed ID: 30695060
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with late antiretroviral therapy initiation in Cameroon: a representative multilevel analysis.
Ndawinz JD; Chaix B; Koulla-Shiro S; Delaporte E; Okouda B; Abanda A; Tchomthe S; Mboui E; Costagliola D; Supervie V
J Antimicrob Chemother; 2013 Jun; 68(6):1388-99. PubMed ID: 23391713
[TBL] [Abstract][Full Text] [Related]
20. Patterns of peripheral neuropathy in ART-naïve patients initiating modern ART regimen.
Lee AJ; Bosch RJ; Evans SR; Wu K; Harrison T; Grant P; Clifford DB
J Neurovirol; 2015 Apr; 21(2):210-8. PubMed ID: 25678143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
